In this episode, we hear from our guest: Michelle Longmire, CEO & Co-Founder at Medable. Topics discussed: Michelle Longmire's Inspiration : In medical school, Longmire recognized a critical access gap in healthcare. Training at the University of New Mexico, she observed the challenges faced by underserved patients and envisioned a technological bridge to healthcare. Formation of Medable : The idea of Medable was shaped by Longmire's experience at Stanford and the rise of mobile technology. ...
Apr 08, 2024•35 min•Ep. 15
In this episode, we hear from our guest: Travis Caudill, VP, Feasibility & Clinical Informatics at ICON. Topics discussed: Travis Caudill shares his journey from a health insurance company to becoming an expert in data migration and feasibility in clinical trials. The evolution of clinical trial data : Travis emphasizes how the industry has dramatically advanced from manual data entry to leveraging sophisticated AI for better decision-making. AI's transformative impact in 2023 and beyond : T...
Mar 25, 2024•18 min•Ep. 14
In this episode, guests Craig Lipset, Founder at Clinical Innovation Partners, and Angela Radcliffe, Founder at How We Mighty Ventures, discuss AI's transformative role in clinical trials. Topics discsued: • The potential and challenges of AI in healthcare. • Strategies for integrating AI in clinical trial processes. • The balance between technological innovation and patient-centric approaches. • Expert Insights: In-depth analysis from leaders in the healthcare and technology sectors. • Reflecti...
Dec 11, 2023•28 min•Ep. 13
In this episode, Omar Khateeb, Founder at Khateeb & Co joins to discuss a MedTech year in review. Listen to discover: Khateeb's background. The three greatest industry or regulatory influences on the medical device or med tech industry this year How he thinks data and innovation have changed how med tech sales teams function How hospital financials are impacting med tech How clinician or clinical worker burnout has affected med tech efforts The three best skills a med device rep can develop ...
Jan 19, 2023•1 hr 1 min•Ep. 12
In this episode Anthony Harries, Honorary Professor at the London School of Hygiene & Tropical Medicine, and Gavin Koh Global Product Lead at AstraZeneca join to discuss their Faculty Opinions perspective on the question "Is Peer Reviewed Research the Answer to Preventing Another Global Health Crisis?". Episode Context: When the pandemic hit and there was a global effort to quickly and effectively develop a COVID-19 vaccine, there was a lot of misinformation shared that lacked scientific mer...
Dec 29, 2022•29 min•Ep. 11
In this episode, Chris Madeiros, Director of Strategy & Solutions at H1 and Nayanica Banerjee, Senior Manager of Client Solutions & Strategy at H1 join to discuss the intersection of KOLs and DOLs while talking about research and medical affairs. Listen to discover: Madeiros & Banerjee's backgrounds in the industry What the term digital opinion leader mean to them, how that has changed over time If they believe DOLs have the same credibility as traditional KOLs Looking into the futur...
Dec 15, 2022•22 min•Ep. 10
In this episode Brad Hightower, CEO at Hightower Clinical, and Darshan Kulkarni, Regulatory and Compliance Attorney for the Life Sciences at The Kulkarni Law Firm join to discuss the 2022 Pharma Year in Review. Listen to discover: The biggest A-Ha moments and challenges for Pharma this year How they see the economic downturn having an impact on the industry Where data or technology innovation had the greatest impact on clinical trials and/or drug developments Whether FDA guidelines will be a mot...
Dec 01, 2022•23 min•Ep. 9
In this episode Meredith Dees, VP of Product at Lokavant & Todd Johnson, VP of Customer Success at Lokavant join to talk about big data, health equity, & the future of clinical trials. Listen to discover: The effect that time & costs have on clinical trials, and how data & analytics can impact these factors for the better Why it is critical to have a connected & consistent source of data for optimized trials to avoid disparities when gathering large amounts of data Lokavant's...
Nov 10, 2022•13 min•Ep. 8
In this episode Jocelyn Levin, Senior Customer Success Manager at H1 joins to discuss her thoughts on customer support & success for Pharma and Life Science companies Listen to discover: Levin's background & journey at H1 How Levin defines customer success & how this translates through different environments such as B2B, health tech, and health start-ups One of the biggest challenges her clients face when utilizing life science data platforms What Levin considers the differences betw...
Oct 27, 2022•14 min•Ep. 7
In this episode Stacey Rivkin, Vice President of Client Solutions & Strategy at H1 joins to discuss Uncut GEMS: how treatment leaders with revolutionize Pharma and where to find them. Listen to discover: Rivkin's background in the industry Some of the changes she's seen in the pharma, biotech and life sciences industry in the last couple years An overview of the different types of key opinion leaders (KOLs) that Medical Affairs teams and Medical Science Liaisons seek out and interact with Th...
Oct 13, 2022•20 min•Ep. 6
In this episode Ariel Katz, Co-Founder & CEO at H1 joins to discuss how AI can transform the way Pharma engages thought leaders. Listen to discover: A quick catch-up with Katz Why healthcare, and more specifically Life Sciences/Pharma, tend to lag in adopting newer technologies like AI? If the data we're receiving now is better, or if we just have a different way to apply it via the new tech H1's recent announcements about how how they are changing the game with new AI powered capabilities w...
Sep 08, 2022•18 min•Ep. 5
In this episode Alexandra Moens, Director of Product Marketing and Adam Wyckoff, Director of Product, Clinical Trials, at H1 join to discuss Divergent Diversity: Where the world is headed with health equity and diversity in clinical trials and bringing drugs to market. Listen to discover: How Moens and Wyckoff have seen the terms diversity and health equity change and evolve in their own experiences How health equity is translated to clinical trials What the biggest barrier to reaching diverse p...
Aug 30, 2022•25 min•Ep. 4
Out guest: Robert Consalvo, Senior Director of Sales Engineering & Enablement at H1 In this episode we discuss: Consalvo's background & role at H1 In terms of medical affairs, pharma and life sciences - what Consalvo means by N.B.A, and what actions he's driving for his intended results? When talking about pharma - why the role of medical affairs is critical to the success of drug launch and development? What roadblocks Consalvo sees some organizations run up against when looking for the...
Jul 27, 2022•14 min•Ep. 3
Our guest: Anatoly Geyfman, VP of Medical Devices at H1 In this episode we discuss: Geyfman's background How Geyfman joined H1 by acquisition of his company Carevoyance, how he saw needs in the market that were not being met, and how H1 fit that vision How Geyfman views himself as a techno-optimist Why it’s even more critical for medical devices to reach underserved populations to achieve better health equity Sponsored by: H1 ( https://www.h1.co/ ) To learn more about H1 please use the links bel...
Jun 28, 2022•20 min•Ep. 2
Our guest: Ariel Katz, CEO & Co-Founder at H1 In this episode we discuss: - Katz's background - Why he started H1 - H1's values and what they stand for in its brand and vision - What the future of H1 innovation looks like Sponsored by: H1 ( https://www.h1.co/ ) To learn more about H1 please use the links below: - Website - LinkedIn Also, be sure to follow Slice of Healthcare on our social channels: - Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter...
May 24, 2022•14 min•Ep. 1
